ESMO Highlights | Professor Wei Yu’s Commentary on Advances in Neoadjuvant Therapy and Bladder Preservation in Bladder Cancer
Editor's Note: Bladder cancer is a common tumor in the urinary system, with muscle-invasive bladder cancer (MIBC) accounting for approximately 20% of all bladder cancers. Nearly half of non-muscle-invasive bladder…